The world is changing fast with a great focus towards digital transformation to increase the productivity and decrease the cost. Making a positive impact on the business outcome is the primary focus during this journey. The fourth Industrial revolution which was introduced through a report during 2013 is getting shaped up as Pharma 4.0 within the Pharmaceutical Industry.
Many of us think that Pharma 4.0 is purely a technical advancement within the Industry, but, it is not. It is all about implementing value driven solutions which have sustainable impact on the business through the adoption of emerging technologies as a part of Industrial Digitalization. Business stakeholders and end user benefits are of prime importance for a successful implementation of a Pharma 4.0 initiative. This is possible only with the help of a collaboration between Business & IT.
The approach on the Digitisation Strategy should be Business-driven rather than the Technology driven one. The gap between the strategy and realisation should be monitored through appropriate governance with the involvement of business & IT. Obviously, the technological advancement happens with a risk of getting exposed to Cyber Security related issues as well.
Here is an opportunity to understand more on Pharma 4.0 from the Subject Matter Experts and Industry Leaders on the fundamentals, how to scope the Pharma 4.0 based on the real business outcome driven approach within an organization, adoption of emerging technologies, Integration of digital information from different sources within the organization, Security considerations and the regulatory considerations while leveraging the emerging technologies by performing right level of validation, controls etc.,
Crystal Mersh, CEO and Executive Partner, Quality Executive Partners
Pharma 4.0: why this change is needed and how we will get there.
David Margetts, Managing Director – AsiaPac, Werum IT Solutions.
GAMP in the Pharma 4.0 world
Dr.Anthony Margetts, Factory Talk, Founding Member of GAMP
Justin M Hoss, US Partner - KPMG National Technology Global Sector Leader - Life Sciences, KPMG
Vipul Doshi, President – Corporate Quality, Zydus Cadila
Integrating data from QC and Production to enable fast, informed decisions
Mike Goetter, Global Head – Informatics, Lonza
Security Integrated approach for Pharma 4.0
Mayur Mehta, Lead Security Architect, Novartis
Infrastructure Qualification and GSDN (Global Software Defined Networks)
Ulrik Jørgensen, Infrastructure Lead, Novo Nordisk, Denmark
Future Lab: How Big Data Analytics is transforming the Pharma Lab & beyond
Dr. Kavita Vengurlekar, Head – Data Science Division, Caliber Technologies
Factory of the Future
Ashit Saxena, Executive Director, Ernst & Young
Digitalization and connectivity revolution in Life Sciences
Priti Ray, Partner / India Lead for Life Sciences, Deloitte
The Drug Supply Chain in a Digital World: An FDA Perspective
Robert A. Rhoades (Bob), Managing Partner, Validant
Assisting the Pharma Industry towards Compliance, and Data Integrity
Nick Townsend, Managing Director - Lab Ware Europe, Labware.
Conquering machine design complexities through integrated automation
Shyam Padwal Lead - Pharma industry vertical B.R. Automation - Mumbai
Automation and digital data to improve speed to market
Data Integrity & Analytics Solutions for Process Automation with respect to pharma 4.0 : Bhavesh Shah - Kevin Technologies Pvt. Ltd.
Please download the registration form , fill it as per the instructions given in the form and make payment to confirm the registration.